Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing

BACKGROUND: Patients with transfusion-dependent thalassemia (TDT) risk iron overload and require iron chelation therapy. Second-line therapy is warranted for patients demonstrating poor chelation responses. PATIENTS AND METHODS: We retrospectively studied the serum-ferritin (SF), and liver-iron-conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Buaboonnam, Jassada, Takpradit, Chayamon, Viprakasit, Vip, Narkbunnam, Nattee, Vathana, Nassawee, Phuakpet, Kamon, Sanpakit, Kleebsabai, Pongtanakul, Bunchoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577551/
https://www.ncbi.nlm.nih.gov/pubmed/34804439
http://dx.doi.org/10.4084/MJHID.2021.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577551/
https://www.ncbi.nlm.nih.gov/pubmed/34804439
http://dx.doi.org/10.4084/MJHID.2021.065

Ejemplares similares